Allogene Therapeutics, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
Rok finansowy 2017 2018 2018 2018 2018 2019 2019 2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024 2025
Kwartał Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1
Data 2017-12-31 2018-03-31 2018-06-30 2018-09-30 2018-12-31 2019-03-31 2019-06-30 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31 2025-03-31
Przychód (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 38 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% inf% inf% inf% inf% -99.84% 95.5% 0.0% -7.84% -14.75% -48.84% -12.24% -55.32% -57.69% -100.00% -100.00% -100.00% -100.00%
Marża brutto 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -inf% -inf% -inf% 89.8% -5243.18% -119736.73% -8217.65% -98516.39% -5538.37% -129779.59% -6938.30% -7042.31% -8520.45% -8206.98% -260190.48% -16059.09% -inf% 0.0% 0.0% 0.0%
Koszty i Wydatki (mln) 0 3 135 22 33 36 46 55 65 58 63 68 69 72 71 78 74 80 77 83 96 99 81 63 72 70 66 72 60 65
EBIT (mln) -0 -3 -135 -22 -33 -36 -46 -55 -65 -58 -63 -68 -69 -33 -71 -78 -74 -80 -77 -82 -96 -99 -81 -63 -72 -70 -66 -72 -60 -65
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 1652200.0% 1304.0% -65.96% 147.9% 95.4% 58.2% 37.4% 23.7% 7.4% -42.44% 12.5% 14.2% 6.5% 140.9% 7.8% 6.2% 30.4% 23.8% 5.1% -23.66% -25.43% -29.84% -17.48% 14.0% -15.83% -6.21%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -86.58% -161429.55% -158510.20% -144888.24% -131134.43% -89062.79% -168344.90% -205051.06% -190519.23% -182995.45% -146453.49% -342209.52% -315927.27% 0.0% 0.0% nan nan
Przychody fiansowe (mln) 0 0 0 1 4 5 5 4 4 3 2 2 2 1 1 0 0 0 0 1 3 2 4 6 6 5 5 7 3 6
Koszty finansowe (mln) 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Amortyzacja (mln) 0 3 0 1 1 1 1 1 2 2 2 2 2 4 2 3 4 4 5 4 3 4 4 4 3 4 4 3 3 3
EBITDA (mln) -0 -3 -135 -40 -30 -36 -45 -54 -59 -56 -61 -66 -64 -31 -69 -75 -70 -76 -73 -79 -93 -96 -77 -59 -68 -66 -63 -63 -56 -56
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -81.58% -156965.91% -153755.10% -144888.24% -125081.97% -84789.53% -160467.35% -205051.06% -190519.23% -174715.91% -138146.51% -325961.90% -299768.18% 0.0% 0.0% nan nan
NOPLAT (mln) -0 -3 -135 -43 -31 -32 -41 -51 -61 -54 -61 -66 -69 -33 -71 -78 -75 -80 -75 -83 -95 -99 -78 -61 -86 -65 -66 -66 -59 -60
Podatek (mln) 0 -3 0 -16 -0 -0 -0 0 -0 -3 -2 -4 -3 -1 -1 -0 -4 -0 -0 -1 -2 -0 -4 -6 -0 4 -0 0 0 0
Zysk Netto (mln) -0 -3 -135 -43 -31 -32 -41 -51 -61 -54 -61 -66 -69 -33 -71 -78 -75 -80 -74 -83 -93 -98 -78 -61 -86 -65 -66 -66 -60 -60
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 1525350.0% 1116.2% -69.43% 16.6% 100.0% 72.5% 47.8% 30.5% 12.4% -39.40% 16.3% 18.1% 9.2% 141.4% 5.0% 6.3% 24.6% 23.4% 4.7% -26.26% -8.08% -33.90% -14.91% 8.1% -30.12% -8.10%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -86.10% -161218.18% -159563.27% -146800.00% -130668.85% -86595.35% -169689.80% -198553.19% -189111.54% -177247.73% -142593.02% -408466.67% -295454.55% 0.0% 0.0% nan nan
EPS 0.0 -0.059 -1.19 -0.38 -0.37 -0.32 -0.41 -0.5 -0.58 -0.5 -0.53 -0.52 -0.53 -0.25 -0.53 -0.57 -0.54 -0.56 -0.52 -0.58 -0.65 -0.68 -0.53 -0.37 -0.51 -0.38 -0.35 -0.32 -0.28 -0.28
EPS (rozwodnione) 0.0 -0.059 -1.19 -0.38 -0.37 -0.32 -0.41 -0.5 -0.58 -0.5 -0.53 -0.52 -0.53 -0.25 -0.53 -0.57 -0.54 -0.56 -0.52 -0.58 -0.65 -0.68 -0.53 -0.37 -0.51 -0.38 -0.35 -0.32 -0.28 -0.28
Ilośc akcji (mln) 44 44 114 114 82 97 100 102 105 109 115 127 130 132 135 137 139 141 143 144 144 145 147 168 168 169 190 209 211 215
Ważona ilośc akcji (mln) 44 44 114 114 82 97 100 102 105 109 115 127 130 132 135 137 139 141 143 144 144 145 147 168 168 169 190 209 211 215
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD